JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB97160

Rabbit Anti-Human IgG H&L (HRP)

Be the first to review this product! Submit a review

|

(7 Publications)

Suitable for ICC, IHC-P, ELISA, WB. Ideal for western blot. Cited in 7 publications.

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1, Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4, Immunoglobulin heavy constant gamma 3, HDC, Heavy chain disease protein, Ig gamma-3 chain C region, IGHG3, Immunoglobulin heavy constant gamma 2, Ig gamma-2 chain C region, Ig gamma-2 chain C region DOT, Ig gamma-2 chain C region TIL, Ig gamma-2 chain C region ZIE, IGHG2

Key facts

Host species

Rabbit

Target species

Human

Target isotype

IgG

Target specificity

Heavy & Light chains

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

HRP

Excitation/Emission
Applications

IHC-P, ELISA, WB, ICC

applications

Clonality

Polyclonal

Isotype

IgG

Specificity

By immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgG and with light chains common to other Human immunoglobulins. No antibody was detected against non immunoglobulin serum proteins.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/200 - 1/5000", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/10000 - 1/100000", "notes":"<p>(Primary).</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/5000 - 1/50000", "notes":"<p>Colorimetric: 1/5000 - 1/30000; Chemiluminescent: 1/10000 - 1/50000</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Horse Radish Peroxidase (HRP).
Storage buffer
pH: 6.8 - 7.4 Preservative: 0.05% CMIT/MIT based preservative Constituents: 0.2% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

Additional targets

IGHG2,IGHG3,IGHG4

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Cell reports. Medicine 5:101573 PubMed38776874

2024

Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection.

Applications

Unspecified application

Species

Unspecified reactive species

Ge-Xin Zhao,Xin-Yan Fang,Guo-Long Bu,Shuai-Jia-Bin Chen,Cong Sun,Ting Li,Chu Xie,Yu Wang,Shu-Xin Li,Ning Meng,Guo-Kai Feng,Qian Zhong,Xiang-Wei Kong,Zheng Liu,Mu-Sheng Zeng

EBioMedicine 88:104439 PubMed36709579

2023

A high-throughput sequencing approach identifies immunotherapeutic targets for bacterial meningitis in neonates.

Applications

Unspecified application

Species

Unspecified reactive species

Stéphanie Pons,Eric Frapy,Youssouf Sereme,Charlotte Gaultier,François Lebreton,Andrea Kropec,Olga Danilchanka,Laura Schlemmer,Cécile Schrimpf,Margaux Allain,François Angoulvant,Hervé Lecuyer,Stéphane Bonacorsi,Hugues Aschard,Harry Sokol,Colette Cywes-Bentley,John J Mekalanos,Thomas Guillard,Gerald B Pier,Damien Roux,David Skurnik

JACS Au 1:1147-1157 PubMed34462738

2021

Multiple Roles of SARS-CoV-2 N Protein Facilitated by Proteoform-Specific Interactions with RNA, Host Proteins, and Convalescent Antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Corinne A Lutomski,Tarick J El-Baba,Jani R Bolla,Carol V Robinson

Cell 176:1420-1431.e17 PubMed30849373

2019

Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus.

Applications

Unspecified application

Species

Unspecified reactive species

Jessica Marcandalli,Brooke Fiala,Sebastian Ols,Michela Perotti,Willem de van der Schueren,Joost Snijder,Edgar Hodge,Mark Benhaim,Rashmi Ravichandran,Lauren Carter,Will Sheffler,Livia Brunner,Maria Lawrenz,Patrice Dubois,Antonio Lanzavecchia,Federica Sallusto,Kelly K Lee,David Veesler,Colin E Correnti,Lance J Stewart,David Baker,Karin Loré,Laurent Perez,Neil P King

Anatomia, histologia, embryologia 47:560-565 PubMed30079545

2018

Tumour necrosis factor receptor-1 is dispensable for the migration of marginal metallophilic macrophages into the B-cell zone of the mouse spleen.

Applications

Unspecified application

Species

Unspecified reactive species

Đorđe N Milićević,Sanja Z Despotović,Jürgen Westermann,Novica M Milićević

Scientific reports 6:31657 PubMed27539094

2016

Microbial Cryptotopes are Prominent Targets of B-cell Immunity.

Applications

ELISA

Species

Unspecified reactive species

Franz J J Rieder,Julia Biebl,Marie-Theres Kastner,Martina Schneider,Christof Jungbauer,Monika Redlberger-Fritz,William J Britt,Michael Kundi,Christoph Steininger

Proceedings of the National Academy of Sciences of 113:7864-9 PubMed27325759

2016

Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Simone M Brändle,Birgit Obermeier,Makbule Senel,Jessica Bruder,Reinhard Mentele,Mohsen Khademi,Tomas Olsson,Hayrettin Tumani,Wolfgang Kristoferitsch,Friedrich Lottspeich,Hartmut Wekerle,Reinhard Hohlfeld,Klaus Dornmair
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com